Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer: From concept to reality

Published on Nov 1, 2018in Pancreas2.92
· DOI :10.1097/MPA.0000000000001167
Jose Serrano49
Estimated H-index: 49
(NIH: National Institutes of Health),
Dana K. Andersen21
Estimated H-index: 21
(NIH: National Institutes of Health)
+ 4 AuthorsJo Ann Rinaudo14
Estimated H-index: 14
(NIH: National Institutes of Health)
: Research progress in diseases of the exocrine pancreas [chronic pancreatitis (CP), pancreatogenic diabetes mellitus, and pancreatic cancer] has been hampered by the disorders' heterogeneity, the limitations of previous small cross-sectional studies, the inability to safely obtain pancreatic tissue for study, and the lack of structured epidemiology tools, genetic testing, and biomarker development. Mechanism-based research of these diseases has suffered from the lack of systematically collected clinical measures in longitudinal cohort studies linked with biospecimens. Given the increasing incidence and prevalence of CP and its association to the development of pancreatic cancer, its complications, high mortality rate, and associated health care cost, the National Institute for Diabetes and Digestive and Kidney Diseases and the National Cancer Institute funded the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer to identify research gaps and foster multidisciplinary collaborations to better diagnose, characterize, and manage CP and its sequelae. The CPDPC structure, governance, and research objectives are described in this article. Studies undertaken by the CPDPC are described in other articles in this journal's issue.
📖 Papers frequently viewed together
38 Citations
22 Authors (Dhiraj Yadav, ..., Darwin L. Conwell)
28 Citations
16 Citations
#1Lola Rahib (University of Texas MD Anderson Cancer Center)H-Index: 2
#1Lola Rahib (Pancreatic Cancer Action Network)H-Index: 12
Last. Lynn M. Matrisian (Pancreatic Cancer Action Network)H-Index: 11
view all 6 authors...
Cancer incidence and deaths in the United States were projected for the most common cancer types for the years 2020 and 2030 based on changing demographics and the average annual percentage changes in incidence and death rates. Breast, prostate, and lung cancers will remain the top cancer diagnoses throughout this time, but thyroid cancer will replace colorectal cancer as the fourth leading cancer diagnosis by 2030, and melanoma and uterine cancer will become the fifth and sixth most common canc...
3,248 CitationsSource
#1Rebecca L. SiegelH-Index: 67
#2Jiemin MaH-Index: 25
Last. Ahmedin JemalH-Index: 139
view all 4 authors...
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data were collected by the National Center for Health Statistics. A total of 1,66...
9,298 CitationsSource
#1Dana K. Andersen (NIH: National Institutes of Health)H-Index: 21
#2Åke Andrén-Sandberg (KI: Karolinska Institutet)H-Index: 33
Last. David C. Whitcomb (University of Pittsburgh)H-Index: 89
view all 8 authors...
A workshop sponsored by the NIDDK and the NCI on “Pancreatitis-Diabetes-Pancreatic Cancer” focused on the risk factors of chronic pancreatitis (CP) and diabetes mellitus (DM) on the development of pancreatic ductal adenocarcinoma (PDAC). Sessions were held on a) an overview of the problem of PDAC, b) CP as a risk factor for PDAC, c) DM as a risk factor for PDAC, d) pancreatogenic, or type 3c DM (T3cDM), e) genomic associations of CP, DM, and PDAC, f) surveillance of high-risk populations and ear...
97 CitationsSource
#1Dhiraj Yadav (University of Pittsburgh)H-Index: 52
#2Albert B. Lowenfels (NYMC: New York Medical College)H-Index: 67
Acute pancreatitis is one of the most frequent gastrointestinal causes of hospital admission in the United States. Chronic pancreatitis, although lower in incidence, significantly reduces patients' quality of life. Pancreatic cancer is associated with a high mortality rate and is one of the top 5 causes of death from cancer. The burden of pancreatic disorders is expected to increase over time. The risk and etiology of pancreatitis differ with age and sex, and all pancreatic disorders affect the ...
1,004 CitationsSource
#1Marina Pasca di Magliano (UM: University of Michigan)H-Index: 31
#2Chris E. Forsmark (UF: University of Florida)H-Index: 49
Last. Anil K. Rustgi (UPenn: University of Pennsylvania)H-Index: 95
view all 11 authors...
The conference “Advances in Acute and Chronic Pancreatitis: From Development to Inflammation and Repair” was held June 25–26, 2012, on the NIH campus, in Bethesda, Maryland (
14 CitationsSource
#1Tom L. Whitlock (Brigham and Women's Hospital)H-Index: 4
#2April S. Tignor (Brigham and Women's Hospital)H-Index: 5
Last. Bechien U. Wu (Brigham and Women's Hospital)H-Index: 23
view all 7 authors...
Background & Aims Reducing rapid readmission of patients after discharge could improve quality of treatment and reduce costs. Little is known about clinical predictors of early readmission for acute pancreatitis (AP). We developed a strategy to identify and stratify patients with AP at risk for readmission within 30 days of discharge. Methods We derived and validated a model in a cohort of patients hospitalized with AP from June 2005–October 2009. Early readmission was defined as admission to th...
38 CitationsSource
#1Sara Raimondi (IEO: European Institute of Oncology)H-Index: 31
#2Albert B. Lowenfels (NYMC: New York Medical College)H-Index: 67
Last. Raffaele PezzilliH-Index: 54
view all 5 authors...
Acute pancreatitis, chronic pancreatitis and pancreatic cancer are responsible for most of the burden of exocrine pancreatic disease. Glandular damage from recurrent bouts of acute pancreatitis can lead to irreversible changes characteristic of chronic pancreatitis. In recent decades accumulating evidence has defined longstanding pre-existing chronic pancreatitis as a strong risk factor for pancreatic cancer. The lag period between diagnosis of chronic pancreatitis and pancreatic cancer is usual...
339 CitationsSource
#1David MalkaH-Index: 57
#2Pascal HammelH-Index: 86
Last. Philippe LévyH-Index: 57
view all 10 authors...
Abstract Background & Aims: The influence of disease progression and pancreatic surgery on the appearance of diabetes mellitus in patients with chronic pancreatitis is unknown. Methods: A prospective cohort study of 500 consecutive patients with chronic pancreatitis (alcoholics, 85%) followed up over a mean period of 7.0 ± 6.8 years in a medical-surgical institution between 1973 and 1996 was performed. Multivariate analysis of risk factors for diabetes mellitus was performed after exclusion of 4...
233 CitationsSource
Cited By13
#1Stephen J. Pandol (Cedars-Sinai Medical Center)H-Index: 74
#2Chris E. Forsmark (UF: University of Florida)H-Index: 49
PURPOSE OF REVIEW To answer several important clinical questions, the Consortium for the study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) research consortium has established several ongoing clinical cohort studies focused on pancreatitis in adults and children, pancreatic cancer, and diabetes associated with pancreatic disease. These will provide a unique resource for clinical and basic science research into these hard-to-treat diseases. RECENT FINDINGS The cause, natural h...
#1Jian-Xiong Hu (Putian University)
#2Chengfei Zhao (Putian University)H-Index: 6
Last. Feng Gao (Fujian Medical University)H-Index: 9
view all 7 authors...
Despite rapid advances in modern medical technology and significant improvements in survival rates of many cancers, pancreatic cancer is still a highly lethal gastrointestinal cancer with a low 5-year survival rate and difficulty in early detection. At present, the incidence and mortality of pancreatic cancer are increasing year by year worldwide, no matter in the United States, Europe, Japan, or China. Globally, the incidence of pancreatic cancer is projected to increase to 18.6 per 100000 in 2...
#1Phil A Hart (NIH: National Institutes of Health)
#2Dana K. Andersen (NIH: National Institutes of Health)H-Index: 21
Last. Mark O. Goodarzi (Cedars-Sinai Medical Center)H-Index: 67
view all 4 authors...
PURPOSE OF REVIEW Diabetes secondary to pancreatic diseases (i.e., acute pancreatitis, chronic pancreatitis, and pancreatic cancer) is increasingly studied, but remains challenging to distinguish from type 2 diabetes (T2DM). We review the clinical significance and potential biomarkers that may help differentiate these types of diabetes. RECENT FINDINGS Recent studies have identified several complications (including nonvascular) that occur more frequently in patients with diabetes secondary to ac...
#1Dana K. AndersenH-Index: 21
#2Suresh T. ChariH-Index: 103
Last. Stephen J. PandolH-Index: 74
view all 7 authors...
#1Barbara J. KennerH-Index: 5
#2Suresh T. Chari (University of Texas MD Anderson Cancer Center)H-Index: 103
Last. Brian M. Wolpin (Harvard University)H-Index: 64
view all 34 authors...
ABSTRACT Despite considerable research efforts, pancreatic cancer is associated with a dire prognosis and a 5-year survival rate of only 10%. Early symptoms of the disease are mostly nonspecific. The premise of improved survival through early detection is that more individuals will benefit from potentially curative treatment. Artificial intelligence (AI) methodology has emerged as a successful tool for risk stratification and identification in general health care. In response to the maturity of ...
#1Zobeida Cruz-Monserrate (The Ohio State University Wexner Medical Center)H-Index: 21
#2Kristyn Gumpper (The Ohio State University Wexner Medical Center)H-Index: 9
Last. Darwin L. Conwell (The Ohio State University Wexner Medical Center)H-Index: 53
view all 19 authors...
Abstract Background Chronic pancreatitis (CP) does not have diagnostic or prognostic biomarkers. CP is the end stage of a progressive inflammatory syndrome that is diagnosed at late stages by morphologic features. To diagnose earlier stages of the disease, a new mechanistic definition was established based on identifying underlying pathogenic processes and biomarker evidence of disease activity and stage. Although multiple risk factors are known, the corresponding biomarkers needed to make a hig...
1 CitationsSource
#2Kristyn GumpperH-Index: 9
Last. Darwin L. ConwellH-Index: 53
view all 23 authors...
Objectives Endoscopic pancreatic function tests are used to diagnose pancreatic diseases and are a viable source for the discovery of biomarkers to better characterize pancreatic disorders. However, pancreatic fluid (PF) contains active enzymes that degrade biomolecules. Therefore, we tested how preservation methods and time to storage influence the integrity and quality of proteins and nucleic acids. Methods We obtained PF from 9 subjects who underwent an endoscopic pancreatic function test. Sa...
#1Stephen P. Pereira (UCL: University College London)H-Index: 61
#2Lucy Oldfield (University of Liverpool)H-Index: 4
Last. Eithne Costello (University of Liverpool)H-Index: 51
view all 14 authors...
Pancreatic ductal adenocarcinoma is most frequently detected at an advanced stage. Such late detection restricts treatment options and contributes to a dismal 5-year survival rate of 3-15%. Pancreatic ductal adenocarcinoma is relatively uncommon and screening of the asymptomatic adult population is not feasible or recommended with current modalities. However, screening of individuals in high-risk groups is recommended. Here, we review groups at high risk for pancreatic ductal adenocarcinoma, inc...
42 CitationsSource
#1Mahendran Jayaraj (UNLV: University of Nevada, Las Vegas)H-Index: 11
#1Mahendran Jayaraj (UNLV: University of Nevada, Las Vegas)H-Index: 7
Last. Gordon Ohning (UNLV: University of Nevada, Las Vegas)H-Index: 4
view all 3 authors...
Purpose of review Chronic pancreatitis in the advanced stages leads to significant health care utilization because of the associated complications. Early-stage diagnosis could prevent the development of these complications by appropriate management. In this article, we reviewed the recent evidence pertaining to the diagnosis and management of early chronic pancreatitis (ECP). Recent findings The working group for the International Consensus Guidelines for Chronic Pancreatitis has published conse...
2 CitationsSource
#1Temel Tirkes (IU: Indiana University)H-Index: 15
#2Dhiraj Yadav (University of Pittsburgh)H-Index: 52
Last. Evan L. Fogel (IU: Indiana University)H-Index: 54
view all 14 authors...
Characteristic features of chronic pancreatitis (CP) may be absent on standard imaging studies. Quantitative Magnetic Resonance Imaging (MRI) techniques such as T1 mapping, extracellular volume (ECV) fraction, diffusion-weighted imaging (DWI) with apparent diffusion coefficient map (ADC), MR elastography (MRE), and T1-weighted signal intensity ratio (SIR) have shown promise for the diagnosis and grading severity of CP. However, radiologists still use the Cambridge classification which is based o...
20 CitationsSource